These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12683265)

  • 1. Understanding the new and evolving profile of adverse drug effects in schizophrenia.
    Wirshing DA; Pierre JM; Erhart SM; Boyd JA
    Psychiatr Clin North Am; 2003 Mar; 26(1):165-90. PubMed ID: 12683265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical health monitoring of patients with schizophrenia.
    Marder SR; Essock SM; Miller AL; Buchanan RW; Casey DE; Davis JM; Kane JM; Lieberman JA; Schooler NR; Covell N; Stroup S; Weissman EM; Wirshing DA; Hall CS; Pogach L; Pi-Sunyer X; Bigger JT; Friedman A; Kleinberg D; Yevich SJ; Davis B; Shon S
    Am J Psychiatry; 2004 Aug; 161(8):1334-49. PubMed ID: 15285957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From chlorpromazine to clozapine--antipsychotic adverse effects and the clinician's dilemma.
    Abidi S; Bhaskara SM
    Can J Psychiatry; 2003 Dec; 48(11):749-55. PubMed ID: 14733456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting and Managing Adverse Effects of Antipsychotic Medications: Current State of Play.
    Ames D; Carr-Lopez SM; Gutierrez MA; Pierre JM; Rosen JA; Shakib S; Yudofsky LM
    Psychiatr Clin North Am; 2016 Jun; 39(2):275-311. PubMed ID: 27216904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics and schizophrenia.
    Foster A; Miller DD; Buckley PF
    Psychiatr Clin North Am; 2007 Sep; 30(3):417-35. PubMed ID: 17720030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iloperidone: a clinical overview.
    Citrome L
    J Clin Psychiatry; 2011; 72 Suppl 1():19-23. PubMed ID: 22217439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management.
    Chue P; Kovacs CS
    Bipolar Disord; 2003; 5 Suppl 2():62-79. PubMed ID: 14700015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
    Rzewuska M
    Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
    Newcomer JW
    J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ejaculatory dysfunction in patient with schizophrenia on sertindole.
    Jukić MK; Drmić S; Mimica N
    Psychiatr Danub; 2010 Mar; 22(1):128-31. PubMed ID: 20305609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Schizophrenia: adverse effects of atypical neuroleptics].
    Bettina Polk B
    Med Monatsschr Pharm; 2003 Feb; 26(2):57-9. PubMed ID: 12619525
    [No Abstract]   [Full Text] [Related]  

  • 15. Health monitoring for patients who have schizophrenia. Summary of the Mount Sinai Conference recommendations.
    Covell NH; Jackson CT; Weissman EM
    Postgrad Med; 2006 Sep; Spec No():20-6. PubMed ID: 17128658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.
    Conley RR; Kelly DL
    Isr J Psychiatry Relat Sci; 2005; 42(1):51-60. PubMed ID: 16134407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current schizophrenia drugs: efficacy and side effects.
    Krebs M; Leopold K; Hinzpeter A; Schaefer M
    Expert Opin Pharmacother; 2006 Jun; 7(8):1005-16. PubMed ID: 16722811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining Side Effect Variability of Antipsychotic Treatment in Schizophrenia Spectrum Disorders: A Meta-analysis of Variance.
    Neumeier MS; Homan S; Vetter S; Seifritz E; Kane JM; Huhn M; Leucht S; Homan P
    Schizophr Bull; 2021 Oct; 47(6):1601-1610. PubMed ID: 34374418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
    Yogaratnam J; Biswas N; Vadivel R; Jacob R
    East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine: diabetes mellitus, weight gain, and lipid abnormalities.
    Henderson DC
    J Clin Psychiatry; 2001; 62 Suppl 23():39-44. PubMed ID: 11603884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.